Audio Recap: EACS 2021
Key Studies Influencing My Practice Following EACS 2021—Audio Recap

Released: November 30, 2021

Expiration: November 29, 2022

Tristan J. Barber
Tristan J. Barber, MA, MD, FRCP

Activity

Progress
1
Course Completed

In this episode, Tristan J. Barber, MA, MD, FRCP, discusses new HIV data from EACS 2021, including:

  • First-line therapies
    • BIC/FTC/TAF in a test-and-treat model in IMEA 055 FAST
    • Week 144 data of ISL + DOR in treatment-naive patients from P011
  • Switch Strategies
    • Data on the use of DTG/3TC in patients with an M184V mutation from SOLAR 3D and the French Dat’AIDS Cohort
  • Long-Acting Therapies
    • Efficacy and safety of LA CAB + RPV by BMI
    • Long-term follow-up of participants who discontinued LA CAB + RPV in the ATLAS, ATLAS-2M, and FLAIR trials
    • Patient satisfaction with LA CAB + RPV from the CARISEL study
    • Resistance and subgroup data from the CAPELLA study of lenacapavir in heavily treatment–experienced patients
  • COVID-19 vaccination efficacy and the impact of the pandemic on viral suppression in PWH